Connect Biopharma Holdings Ltd ADR (NASDAQ: CNTB): Do Not Miss The Gain Train

Connect Biopharma Holdings Ltd ADR (CNTB) concluded trading on Thursday at a closing price of $1.74, with 0.47 million shares of worth about $0.82 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 138.36% during that period and on March 28, 2024 the price saw a gain of about 8.07%. Currently the company’s common shares owned by public are about 55.04M shares, out of which, 53.08M shares are available for trading.

Stock saw a price change of 40.32% in past 5 days and over the past one month there was a price change of 47.46%. Year-to-date (YTD), CNTB shares are showing a performance of 47.46% which increased to 112.20% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.53 but also hit the highest price of $2.84 during that period. The average intraday trading volume for Connect Biopharma Holdings Ltd ADR shares is 135.56K. The stock is currently trading 37.55% above its 20-day simple moving average (SMA20), while that difference is up 43.41% for SMA50 and it goes to 57.97% higher than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Connect Biopharma Holdings Ltd ADR (NASDAQ: CNTB) currently have 55.04M outstanding shares and institutions hold larger chunk of about 7.42% of that.

The stock has a current market capitalization of $95.82M and its 3Y-monthly beta is at -0.64. It has posted earnings per share of -$1.59 in the same period. It has Quick Ratio of 9.26 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CNTB, volatility over the week remained 13.15% while standing at 11.71% over the month.

Analysts are in expectations that Connect Biopharma Holdings Ltd ADR (CNTB) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter EPS is $0 and it is -$0.54 for next year. For the current quarter EPS, analysts have given the company a lowest target $0 which is $0 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 62.03% while it is estimated to increase by 124.84% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on March 04, 2024 offering a Buy rating for the stock and assigned a target price of $7 to it. Coverage by SVB Leerink stated Connect Biopharma Holdings Ltd ADR (CNTB) stock as an Outperform in their note to investors on April 13, 2021, suggesting a price target of $32 for the stock. On April 13, 2021, Piper Sandler Initiated their recommendations, while on April 13, 2021, Jefferies Initiated their ratings for the stock with a price target of $27.

Most Popular

Related Posts